NCI Doug Lowy: NCI to fund MCED research, early-stage investigator diversity in Moonshot 2.0 June 17, 2022Vol.48 No.24By Alice Tracey
FreeObituary Neuroblastoma researcher Robert C. Seeger dies at 82 June 17, 2022Vol.48 No.24By Katherine K. Matthay, Judith G. Villablanca, C. Patrick Reynolds and John M. Maris
FreeIn the Archives Dave Boule confronted polycythemia vera with an accountant’s consistency June 17, 2022Vol.48 No.24
Trials & Tribulations ANCHOR trial shows that treatment of anal high-grade squamous intraepithelial lesions prevents anal cancer in people with HIV June 17, 2022Vol.48 No.24By Joel M. Palefsky and Robert Yarchoan
EditorialFree The Cancer Letter receives 7 journalism, design awards June 17, 2022Vol.48 No.24By Katie Goldberg
Guest Editorial ASCO’s “rock concert” moments came 17 years apart—in 2005 and 2022DESTINY-04 results extend HER2-targeted therapy to a larger population in breast cancer June 10, 2022Vol.48 No.23By George W. Sledge Jr.
In early results “unprecedented in rectal cancer,” 14/14 patients show clinical complete response to dostarlimab June 10, 2022Vol.48 No.23By Alice Tracey
Lowy calls for expanding NCI’s clinical impact, including: (1) the number of drug candidates, (2) the clinical trials system, and (3) access to cancer care June 10, 2022Vol.48 No.23By Alice Tracey
FreeObituary Moffitt’s Robert Gillies, “father of radiomics,” dies at 69 June 10, 2022Vol.48 No.23By Kim Polacek
FreeObituary Lucius Sinks, a giant in pediatric cancer, dies at 91“We were able to come together at Roswell Park and help the kids.” June 10, 2022Vol.48 No.23By Tim Wendel
